SEC Form 4 · accession 0000899243-18-012922
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B. Pearce
Officer — Chief Compliance Officer
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2018 | S | 984 | $71.55 | D | 15,206 | D | |
| Common Stock | May 11, 2018 | M | 3,659 | $52.61 | A | 18,865 | D | |
| Common StockF1 | May 11, 2018 | S | 355 | $70.80 | D | 18,510 | D | |
| Common StockF2 | May 11, 2018 | S | 3,304 | $71.53 | D | 15,206 | D | |
| Common StockF3 | holding | — | — | — | 207 | I | Through 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $52.61 | May 11, 2018 | M | 3,659 | D | — | Jul 20, 2026 | Common Stock | 3,659 | 10,976 | D |
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.62 to $70.91, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.85, inclusive.
- F3The information in this report is based on a plan statement dated as of March 31, 2018.
- F4The Stock Options are subject to time-based vesting conditions. 3,659 Stock Options vested on July 20, 2017 and the remaining 10,976 Stock Options will vest in approximately equal installments on each of July 20, 2018, July 20, 2019 and July 20, 2020, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.